Vaccination is the only best way of treating flu caused by H1N1 influenza virus. There are two types of vaccines to treat swine flu depending on the nature of virus inserted. These include flu shot - contains inactivated virus and FluMist - contains live virus. Flu shot is inactivated vaccine containing a killed virus and injected in the arm muscle. Intramuscular vaccine or the flu shot costs less as compared to FluMist and hence caters to larger percent of population. The FluMist vaccine contains attenuated live virus and is given through nasal track. Though the FLuMist vaccine has limited customers, this is the most effective form of vaccine with fewer side effects.The rate of penetration of these vaccinations is analyzed and an in depth analysis of the same is provided in the report. There could be chances of some side effects after the injection of vaccine in the body. Some of them include - weakness, vision problem, problem in speaking, swallowing, or bladder and bowel functions, severe lower back pain, slow heart rate, trouble breathing, high fever, or unusual bruising or bleeding.
The report highlights the major brands producing vaccines for H1N1. The major drug brands include Agripal, Fiuarix, Influgen, Influvac, Nasovac, Vaxigrip, and others. These brands are produced by the leading players in vaccine industry. Due to the increasing deaths caused by H1N1, government of all nations including the U.S., Russia, and India have provided huge subsidies to the vaccine manufacturers. Moreover, the government is forming strong partnerships with the vaccine providers to promote the use of vaccines. These are the major factors boosting the growth of H1N1 vaccine market. However, many doctors in India and other countries are reluctant to get injected with these vaccines as they believe they are developing automatic immunity while treating swine flu patients. Besides the high cost of vaccine and lengthy and complex manufacturing process are posing great challenge to the growth of H1N1 vaccine market. The report identifies the major dynamics in H1N1 vaccine market including drivers, inhibitors, challenges and opportunities. The impact analysis of these factors is also included in the report. The report tracks and analyzes the key trends, macro factors and micro factors in the market. The entire value chain of the market along with the suppliers and distributor analysis is also included in the report.
The report provides precise and comprehensive insights on the H1N1 vaccine market in all geographies such as North America, Europe, Asia-Pacific, and Latin America. The U.S. accounts for highest share due to the high adaptive rate of the medications and disease awareness. India has high growth potential in this market due to the steps taken by Indian government towards spreading awareness and motivating the private vaccine manufacturers by forming strategic partnerships and offering good subsidies. Moreover, the countries generating high revenue globally have also been analyzed along with exhaustive coverage of developments and innovation in these countries.
The report also offers extensive research on the key players in this market and detailed insights on the competitiveness of these players. The key business strategies such as mergers & acquisitions, partnerships, collaborations, and contracts adopted by the major players are also identifies and analyzed in the report.
The major players profiled in the report include
Panacea Biotec Ltd.,
Lupin Laboratories Ltd.,
Baxter International Inc.,
Crucell N.V., and
Green Cross Corp.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. H1N1 Vaccine Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. End-User Profiling
3.2.2. Financial Analysis of Top 5 Players
4. H1N1 Vaccine Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of Industry
4.4.1. Power of Supplier
4.4.2. Power of Consumer
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. H1N1 Vaccine Market Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunity Analysis
5.4. Product Life Cycle Analysis
5.5. Suppliers & Distributors
6. H1N1 Vaccine Market - By Vaccine Type
6.1. Flu shot/ Inactivated Vaccine
6.2. Nasal Spray/FluMist/Intranasal
7. H1N1 Vaccine Market - By Type of Brand
8. H1N1 Vaccine Market - By Geography
8.1. North America
8.1.1. The U.S.
8.1.3. Rest of North America
8.2.1. The U.K.
8.2.5. Rest of Europe
8.3.4. Rest of APAC
8.4. Latin America
8.4.4. Rest of Latin America
8.5. Rest of the World
8.5.1. The Middle East
9. H1N1 Vaccine Market Entropy
9.1. New Product Launches
9.2. M&As, Collaborations, Partnerships & JVs
10. Company Profiles (Overview, Financials, Products & Services, Recent Developments, Competitors & Customers)
10.1. Panacea Biotec Ltd.
10.2. Glaxo Smithkline Pharmaceuticals Ltd.
10.3. Lupin Laboratories Ltd.
10.4. Solvay Pharma India Pvt. Ltd.
10.5. Serum Institute of India Ltd.
10.6. Sanofi Pasteur
10.7. Baxter International Inc
10.8. Butantan Institute
10.9. Crucell N.V.
10.10. Green Cross Corp
"*Financials would be provided on a best efforts basis for private companies"
11.3. Research Methodology
11.5. Compilation of Expert Insights